UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2022 | 2022-11-08 | Future report Set alerts | |
| Q4 2021 | 2022-09-08 | -0.12 | -0.12 |
| Q3 2021 | 2022-05-23 | -0.07 | -0.07 |
| Q2 2021 | 2022-02-10 | -0.05 | -0.05 |
| Q1 2021 | 2021-11-10 | -0.11 | -0.11 |
| Q4 2020 | 2021-09-02 | -0.05 | -0.05 |
| Q3 2020 | 2021-05-06 | -0.28 | -0.28 |
| Q2 2020 | 2021-02-04 | -0.10 | -0.10 |
| Q1 2020 | 2019-11-07 | -0.04 | -0.04 |
| Q4 2019 | 2019-08-28 | -0.15 | -0.15 |
| 2016-04-18 | Lower Price Target | Wedbush | Neutral | $3.00 to $2.00 |
| 2015-10-07 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-09-04 | Reiterated Rating | Wedbush | Hold | |
| 2015-09-02 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2015-06-12 | Set Price Target | Wedbush | Hold | $3.00 |
| 2015-03-24 | Downgrade | Bank of America | Buy to Neutral | |
| 2015-03-24 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | $2.25 to $2.00 |
| 2015-03-24 | Reiterated Rating | Cantor Fitzgerald | Buy | $14.00 to $7.00 |
| 2015-03-24 | Downgrade | Wells Fargo | Outperform to Market Perform | $2.25 to $2.00 |
| 2015-03-24 | Downgrade | Bank of America Corp. | Buy to Neutral | |
| 2015-03-23 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-03-23 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2015-03-23 | Downgrade | Wedbush | Outperform to Neutral | $12.00 to $3.00 |
| 2015-03-23 | Downgrade | Roth Capital | Buy to Neutral | $14.00 to $2.50 |
| 2015-03-11 | Reiterated Rating | Cantor Fitzgerald | Buy | $14.00 |
| 2015-02-20 | Initiated Coverage | Bank of America | Buy | $9.00 |
| 2015-02-08 | Reiterated Rating | Cantor Fitzgerald | Buy | $14.00 |
| 2015-02-06 | Initiated Coverage | Wells Fargo & Co. | Outperform | $10.50 |
| 2015-02-06 | Initiated Coverage | Wells Fargo | Outperform | $10.50 |
| 2014-12-23 | Set Price Target | Cantor Fitzgerald | Buy | $14.00 |
| 2014-12-18 | Lower Price Target | Roth Capital | Buy | $22.00 to $14.00 |
| 2014-10-16 | Reiterated | ROTH Capital | Buy | $20 to $22 |
| 2014-10-16 | Boost Price Target | Roth Capital | Focus List | $20.00 to $22.00 |
| 2014-09-08 | Initiated Coverage | Cantor Fitzgerald | Buy | $14.00 |
| 2014-07-08 | Initiated Coverage | Brean Capital | Buy | $16.00 |
| 2014-01-10 | Initiated Coverage | Brean Capital | Buy | $16.00 |
| 2013-12-05 | Initiated Coverage | Wedbush | Outperform | $12.00 |
| 2013-10-22 | Boost Price Target | Stifel Nicolaus | Buy | $11.00 to $15.00 |
| 2013-10-21 | Boost Price Target | Roth Capital | Buy | $16.00 to $20.00 |
| 2016-04-18 | Lower Price Target | Wedbush | Neutral | $3.00 to $2.00 |
| 2015-10-07 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-09-04 | Reiterated Rating | Wedbush | Hold | |
| 2015-09-02 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2015-06-12 | Set Price Target | Wedbush | Hold | $3.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MEIP 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| NOVOGEN LTD | 82.55% (17837246) | MEIP / |
| VIVO VENTURES VII, LLC | 14.64% (3163105) | CDXS / MEIP / |
| GOLD DANIEL P PHD President and Chief Executive | 1.25% (271080) | MEIP / |
| Vivo Ventures V, LLC | 0.85% (183767) | CAPN / MEIP / SGNT / |
| Baltic Charles V. III | 0.11% (24250) | MEIP / |
| JOHNSTON PHILIP A | 0.05% (10000) | MEIP / |
| SEATON DAVID R CFO & Secretary | 0.02% (5000) | MEIP / |
| NAUGHTON CHRISTOPHER CEO & President | 0.02% (5000) | MEIP / |
UM